Matthew Perrone
- Indexed articles, last 90 days
- 3
- Latest publication
- Jul 24, 2026
- Outlet visibility, for Fortune
- Top 10K sites
- Earliest in this view
- Jul 16, 2026
Latest articles
RFK Jr.'s peptide push narrowly gains backing from FDA advisers despite objections from scientists | Fortune (opens the original)
Read excerpt
A panel of federal health advisers on Thursday narrowly recommended easing access to several peptides popular with wellness influencers and celebrities, despite warnings from government scientists that the chemicals haven’t been shown to be safe or effective. In a series of votes, outside experts to the Food and Drug Administration advised the agency to drop current restrictions barring pharmacies from producing injectable peptides with names including BPC-157, TB-500 and KPV. The panel’s vote i
The cholesterol shot you couldn’t afford is now a pill | Fortune (opens the original)
Read excerpt
The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that’s previously only been available with expensive, injectable drugs. The drug from Merck was OK’d on Thursday for patients with artery-clogging cholesterol that persists even after taking statins, the standard medications for cutting heart attack risk. Merck will market its pill under the brand name Lipfendra. It’s the first noninjectable medication that works by blocking a
Only 12% of testosterone prescriptions are medically necessary — and Trump wants to make that ratio even smaller | Fortune (opens the original)
Read excerpt
Officials under President Donald Trump want to make it easier for men to get a prescription for testosterone, the latest shift in a decades-long debate over the benefits and risks of replacing the hormone that affects sex drive, mood and other health factors. The move, backed by Health Secretary Robert F. Kennedy Jr. and other top officials, aligns with the advice of many online influencers and podcasters, including men’s health gurus who tout the hormone as a way to boost muscle and energy. On
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 10K sites
For Fortune, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.